GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001227 describes a molecular function in which a DNA-binding transcription factor represses or decreases transcription of specific gene sets transcribed by RNA polymerase II.
• This activity is sequence-specific and can occur at proximal promoters or distal enhancers, as reflected in the official synonyms of the term.
• The transcriptional coactivator PC4/Sub1 has multiple functions in RNA polymerase II transcription, including roles that intersect with repressive regulation.
• General transcription factor TFIIA, including the testis-specific TFIIAtau, stimulates TATA-binding protein-DNA binding and transcription activation, providing a counterpoint to repressor activity.
• Dysregulation of RNA polymerase II-specific repressors such as HIC1 is linked to cancer and developmental disorders, making this GO term clinically relevant.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of genes annotated with GO:0001227.
Description
GO:0001227, DNA-binding transcription repressor activity, RNA polymerase II-specific, is a molecular function ontology term that defines the ability of a transcription factor to bind DNA in a sequence-specific manner and repress or decrease transcription of specific gene sets transcribed by RNA polymerase II. This term captures a fundamental regulatory activity that shapes gene expression programs during development, differentiation, and homeostasis. Unlike general transcriptional repressors that act without DNA binding, proteins with this activity directly recognize regulatory elements such as proximal promoters or distal enhancers and recruit co-repressors to dampen RNA polymerase II output. The official synonyms of GO:0001227 emphasize metal ion-regulated sequence-specific DNA binding and negative regulation of transcription, highlighting the diversity of mechanisms that fall under this single ontology node. Understanding this activity is essential because precise control of RNA polymerase II transcription is required for normal cell function, and its disruption contributes to diseases including cancer. Experimental dissection of repressor function often requires complementary approaches, such as computational analysis of sequence variants and biochemical assays of transcription factor activity. For example, computational analysis of single nucleotide polymorphisms in the human HIC1 gene, a sequence-specific transcriptional repressor, illustrates how variants can affect repressor function and disease risk. At the same time, studies of coactivators such as PC4/Sub1 reveal that RNA polymerase II regulation is a balance between activating and repressive inputs. Similarly, general transcription factors like TFIIA and its testis-specific variant TFIIAtau stimulate TATA-binding protein-DNA binding and transcription activation, underscoring that repressor activity must be understood within the broader context of the RNA polymerase II machinery. Researchers studying GO:0001227 therefore need robust models to test whether a candidate repressor causally affects transcription and phenotype.
DNA-binding transcription repressor activity, RNA polymerase II-specific At A Glance
| GO ID | GO:0001227 |
|---|---|
| GO term | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| Ontology | molecular_function |
| Synonym | RNA polymerase II transcriptional repressor activity; transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; distal enhancer DNA-binding transcription repressor activity, RNA polymerase II-specific |
| Major function | Sequence-specific DNA binding and repression of RNA polymerase II transcription of specific gene sets |
| Definition source | QuickGO definition: A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II |
| Regulatory location | Proximal promoter and distal enhancer regions |
| Ion dependence | Some synonyms indicate metal ion-regulated sequence-specific DNA binding |
| Related activity | Contrasts with transcription activator activities such as those mediated by TFIIA and PC4/Sub1 |
What Is GO:0001227?
In simple terms, GO:0001227 describes a protein that binds to specific DNA sequences and acts as a brake on transcription by RNA polymerase II. The QuickGO definition states that it is a DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II. This activity is sequence-specific, meaning the repressor recognizes particular regulatory DNA elements, and it can occur at core promoter proximal regions or distal enhancers. The term also encompasses metal ion-regulated DNA binding, indicating that some repressors require metal ions for their DNA-binding function. Importantly, GO:0001227 is a molecular function, not a biological process; it describes what the protein does at the molecular level, while the downstream effects on gene expression programs are captured by associated biological process terms.
Why Is DNA-binding transcription repressor activity, RNA polymerase II-specific Important in Cell Biology?
GO:0001227 is important because sequence-specific transcriptional repression by RNA polymerase II is a central mechanism for controlling gene expression programs, and its dysregulation is implicated in human disease. Computational analysis of single nucleotide polymorphisms in the human HIC1 gene, a transcriptional repressor, demonstrates how genetic variation in repressor proteins can be analyzed for functional impact and disease association. The balance between repressive and activating inputs at RNA polymerase II-transcribed genes is also illustrated by the multiple functions of the coactivator PC4/Sub1, which participates in both activation and repression contexts. Furthermore, general transcription factors such as TFIIA and its testis-specific variant TFIIAtau stimulate TATA-binding protein-DNA binding and transcription activation, providing a mechanistic counterpoint that helps define what repression must overcome. Understanding GO:0001227 therefore informs studies of development, cancer, and other conditions where transcriptional control goes awry.
• Defines a core molecular function required for precise spatiotemporal control of RNA polymerase II-transcribed genes.
• Enables sequence-specific targeting of repressive complexes to proximal promoters and distal enhancers.
• Provides a mechanistic counterbalance to transcriptional activators such as TFIIA and PC4/Sub1.
• Dysregulation of repressor proteins like HIC1 is associated with cancer and developmental disorders.
• Supports interpretation of non-coding and coding variants in repressor genes through computational and functional analysis.
• Guides CRISPR-based causal tests of whether a candidate gene represses transcription in a given cell type.
• Helps explain context-dependent gene expression changes observed in differentiation and disease.
• Informs drug discovery efforts targeting transcriptional repression pathways in oncology.
• Facilitates annotation of RNA polymerase II regulatory networks in genome-wide studies.
• Connects molecular function to phenotype through integrated computational and experimental workflows.
Mechanism, Genes and Research Methods
What Happens During DNA-binding transcription repressor activity, RNA polymerase II-specific?
In simple terms: A repressor protein finds a specific DNA sequence and tells the transcription machinery to slow down or stop making RNA from that gene.
During GO:0001227 activity, a sequence-specific DNA-binding protein recognizes regulatory elements in the genome and represses transcription of specific gene sets transcribed by RNA polymerase II. This can occur at core promoter proximal regions or at distal enhancers, as reflected in the official synonyms of the term. The repressor may compete with activators, recruit co-repressors, or stabilize a repressed chromatin state, ultimately decreasing RNA polymerase II output. Computational analysis of single nucleotide polymorphisms in the human HIC1 gene illustrates how sequence variation in a repressor can be analyzed for potential effects on this activity. The broader RNA polymerase II regulatory environment includes coactivators such as PC4/Sub1, which has multiple functions in transcription and can influence the balance between activation and repression. General transcription factors like TFIIA and TFIIAtau stimulate TATA-binding protein-DNA binding and activation, highlighting the steps that repressors must counteract.
Sequence-specific DNA recognition at promoters and enhancers
In simple terms: The repressor has a shape that fits a particular DNA sequence, like a key in a lock, so it only binds where it is supposed to act.
The defining feature of GO:0001227 is DNA-binding transcription repressor activity that is RNA polymerase II-specific and sequence-specific. The term's synonyms explicitly include proximal promoter DNA-binding transcription repressor activity and distal enhancer DNA-binding transcription repressor activity, indicating that repressors can act at different regulatory locations. Some synonyms also specify metal ion-regulated sequence-specific DNA binding, suggesting that metal ions can modulate the DNA-binding step for certain repressors. This sequence specificity ensures that repression is targeted to particular gene sets rather than globally shutting down transcription. Computational approaches can predict how variants in the DNA-binding domain of a repressor such as HIC1 might alter this recognition step.
Repression of RNA polymerase II transcription
In simple terms: Once bound, the repressor reduces the amount of RNA polymerase II that successfully transcribes the target genes.
After DNA binding, a repressor with GO:0001227 activity decreases transcription of specific gene sets transcribed by RNA polymerase II. This repression can involve interference with activator recruitment, recruitment of co-repressor complexes, or modulation of chromatin accessibility. The RNA polymerase II transcription cycle includes steps that are stimulated by factors such as TFIIA and TFIIAtau, which enhance TATA-binding protein-DNA binding and activation; repressors must oppose or bypass these activating inputs. The coactivator PC4/Sub1 has multiple functions in RNA polymerase II transcription, and its dual roles illustrate the complex regulatory balance in which repression operates. Measuring the decrease in nascent or steady-state RNA from target genes is a common way to assay this activity.
Integration with cofactors and the general transcription machinery
In simple terms: The repressor does not work alone; it interacts with other proteins that help or hinder the transcription machinery.
GO:0001227 activity is embedded in a network of cofactors and general transcription factors. PC4/Sub1 is a transcriptional coactivator with multiple functions in RNA polymerase II transcription, and its activities can intersect with repressive regulation depending on context. TFIIA and its testis-specific variant TFIIAtau stimulate TATA-binding protein-DNA binding and transcription activation, representing activating inputs that repressors may need to overcome. The interplay between repressors, coactivators, and general transcription factors determines the net transcriptional output of a gene. Experimental dissection of these interactions often requires perturbation of individual components followed by measurement of target gene expression.
Regulation of repressor activity
In simple terms: The repressor itself can be turned on or off by signals inside the cell, so repression is dynamic.
The activity of DNA-binding transcription repressors can be regulated at multiple levels, including DNA binding, cofactor recruitment, and post-translational modification. The presence of metal ion-regulated synonyms for GO:0001227 indicates that metal ions can influence the DNA-binding step for some repressors. Computational analysis of SNPs in HIC1 provides a framework for predicting how sequence changes might affect repressor regulation and function. The broader RNA polymerase II machinery, including coactivators like PC4/Sub1 and general factors like TFIIA, contributes to the regulatory environment that shapes repressor output. Understanding these regulatory layers is essential for interpreting gene expression changes in disease and development.
Key Genes Involved in GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
The following genes and proteins are representative of the sequence-specific RNA polymerase II repressor machinery and its regulatory context, based on the verified literature and the GO:0001227 definition.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIC1 | Sequence-specific transcriptional repressor with roles in development and tumor suppression | Computational analysis of SNPs in HIC1 illustrates variant impact on repressor function |
| PC4/Sub1 | Transcriptional coactivator with multiple functions in RNA polymerase II transcription | Provides context for the balance between activation and repression |
| TFIIA | General transcription factor that stimulates TATA-binding protein-DNA binding and activation | Represents an activating input that repressors must counteract |
| TFIIAtau | Testis-specific TFIIA variant that stimulates TATA-binding protein-DNA binding and transcription activation | Illustrates tissue-specific regulation of RNA polymerase II transcription |
| TBP | TATA-binding protein that nucleates preinitiation complex assembly | Central node for both activation and repression at RNA polymerase II promoters |
| RNA polymerase II | Enzyme responsible for transcribing protein-coding genes | Direct target of repression by GO:0001227 proteins |
| Co-repressor complexes | Mediate chromatin modification and transcriptional silencing | Recruited by sequence-specific repressors to decrease transcription |
| Chromatin remodeling factors | Alter nucleosome positioning to modulate accessibility | Contribute to repressive states at target genes |
| Mediator complex | Bridges transcription factors and RNA polymerase II | Integrates activating and repressive signals |
| Histone deacetylases | Remove acetyl groups to promote compact chromatin | Common effectors of transcriptional repression |
| Histone methyltransferases | Deposit repressive histone marks | Contribute to stable gene silencing |
| DNA methyltransferases | Establish DNA methylation at regulatory regions | Can reinforce long-term repression |
| Krüppel-like factors | Sequence-specific DNA-binding transcription factors with repressive potential | Model family for studying GO:0001227 activity |
| Nuclear receptors | Ligand-regulated transcription factors that can repress target genes | Illustrate metal ion and ligand-regulated DNA binding |
| Zinc finger proteins | Large family of sequence-specific DNA-binding proteins | Many members function as repressors in RNA polymerase II transcription |
| BTB domain proteins | Scaffold co-repressor complexes | Link sequence-specific repressors to chromatin modifiers |
| Groucho/TLE family | Corepressors recruited by DNA-binding repressors | Model system for repressor-cofactor interactions |
How Is DNA-binding transcription repressor activity, RNA polymerase II-specific Regulated?
The activity described by GO:0001227 is regulated at multiple levels, including DNA binding, cofactor recruitment, and post-translational modification. The presence of metal ion-regulated synonyms indicates that metal ions can modulate the DNA-binding step for some repressors. Computational analysis of SNPs in the HIC1 gene provides a framework for predicting how sequence variants affect repressor regulation and function. The broader RNA polymerase II regulatory environment includes coactivators such as PC4/Sub1, which has multiple functions in transcription and can influence the balance between activation and repression. General transcription factors like TFIIA and TFIIAtau stimulate TATA-binding protein-DNA binding and activation, representing activating inputs that repressors must overcome. Together, these layers determine the net repressive output at target genes.
DNA-binding transcription repressor activity, RNA polymerase II-specific and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIC1 | Cancer and developmental disorders associated with transcriptional repression | Knockout and point-mutation models in cancer cell lines |
| PC4/Sub1 | Transcriptional dysregulation in cancer and other diseases | Overexpression and knockout models to test coactivator function |
| TFIIA | Developmental and tissue-specific transcriptional disorders | Knock-in and point-mutation models to dissect general transcription factor function |
| TFIIAtau | Testis-specific transcriptional regulation and fertility | Tissue-specific knockout and overexpression models |
| RNA polymerase II subunits | Broad transcriptional dysregulation in disease | Knockout and tagged knock-in models for interaction studies |
Cancer and tumor suppression
Sequence-specific transcriptional repressors such as HIC1 are implicated in cancer biology, and computational analysis of single nucleotide polymorphisms in HIC1 can reveal variants that may affect repressor function and disease risk. Loss of repressor activity can lead to inappropriate activation of target genes that promote proliferation or survival. The balance between repressive and activating inputs at RNA polymerase II-transcribed genes, including coactivator functions of PC4/Sub1, is relevant to oncogenic transcription programs. Studying GO:0001227 in cancer models can help identify vulnerabilities associated with transcriptional dysregulation.
Developmental disorders
Precise repression of RNA polymerase II transcription is required for normal development, and disruption of sequence-specific repressors can cause developmental abnormalities. The tissue-specific general transcription factor TFIIAtau, which stimulates TATA-binding protein-DNA binding and activation, illustrates how specialized transcriptional regulation contributes to tissue-specific programs. Repressors with GO:0001227 activity help shape these programs by dampening inappropriate gene expression. Computational and functional analysis of repressor variants can inform developmental disease mechanisms.
Transcriptional dysregulation in disease
Dysregulation of RNA polymerase II transcription is a common theme in many diseases, and repressors annotated with GO:0001227 are key nodes in these regulatory networks. The multiple functions of PC4/Sub1 in RNA polymerase II transcription highlight how coactivator and repressor activities can be intertwined in disease contexts. General transcription factors such as TFIIA and TFIIAtau provide activating inputs that, when unbalanced with repression, can contribute to pathological gene expression. Understanding these interactions supports the development of targeted therapeutic strategies.
From DNA-binding transcription repressor activity, RNA polymerase II-specific-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate repressor increase target gene transcription? | CRISPR knockout cell model followed by RNA-seq |
| Does a specific point mutation in a repressor DNA-binding domain alter repression? | CRISPR point-mutation knock-in model |
| Does a disease-associated SNP affect repressor function? | Knock-in of the variant allele and transcriptional reporter assays |
| Where does the repressor bind genome-wide? | Tagged knock-in with ChIP-seq or CUT&RUN |
| Does overexpression of a repressor decrease target gene expression? | CRISPR overexpression model with RNA-seq readout |
| Which cofactors are required for repression? | Knockout of candidate cofactors in a repressor-expressing background |
How to Study the DNA-binding transcription repressor activity, RNA polymerase II-specific Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global changes in RNA levels | Assessing transcriptional consequences of repressor perturbation |
| qRT-PCR | Expression of specific target genes | Validating repression of candidate targets |
| ChIP-seq | Genome-wide DNA binding of a repressor | Mapping promoter and enhancer occupancy |
| CUT&RUN | DNA binding with low input | Profiling repressor occupancy in rare cell populations |
| Reporter assays | Activity of regulatory elements | Testing sequence-specific repression |
| Computational SNP analysis | Predicted impact of sequence variants | Prioritizing variants in repressor genes like HIC1 |
| Co-immunoprecipitation | Protein-protein interactions | Identifying co-repressor complexes |
| CRISPR screening | Phenotypes of gene perturbations | Discovering regulators of repressor activity |
Transcriptional readouts for repressor activity
Measuring changes in RNA levels of target genes is a direct way to assay GO:0001227 activity. RNA-seq can quantify global transcriptional changes upon repressor perturbation, while targeted qRT-PCR can validate specific targets. Computational analysis of SNPs in repressor genes such as HIC1 can prioritize variants for functional testing in these assays. Comparing activating and repressive conditions helps distinguish direct effects from secondary changes.
DNA-binding and chromatin occupancy assays
ChIP-seq, CUT&RUN, and related methods can map where a repressor binds across the genome. These assays test the sequence-specific DNA-binding component of GO:0001227 and can identify proximal promoter versus distal enhancer occupancy. Tagged knock-in models enable occupancy profiling without overexpression artifacts. Integrating binding data with transcriptional changes helps establish direct repression targets.
Biochemical and computational analysis of repressor variants
Computational analysis of single nucleotide polymorphisms in HIC1 demonstrates how sequence variants can be assessed for potential impact on repressor function. Biochemical assays of DNA binding and transcription factor activity can test predictions from computational models. The multiple functions of PC4/Sub1 in RNA polymerase II transcription illustrate the value of biochemical dissection of cofactor roles. General transcription factor studies, such as those on TFIIA and TFIIAtau, provide mechanistic context for repression assays.
Perturbation and rescue experiments
Knockout, knockdown, and rescue experiments can establish causality for a candidate repressor. Overexpression models can test sufficiency of repression, while loss-of-function models test necessity. Combining these perturbations with transcriptional readouts and binding assays provides a comprehensive view of GO:0001227 activity. Cofactor perturbation studies, informed by work on PC4/Sub1 and TFIIA, can reveal dependencies.
How CRISPR Can Be Used to Study GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
Knockout
CRISPR knockout of a candidate repressor gene can test whether loss of function increases transcription of target genes, providing causal evidence for GO:0001227 activity. Knockout models are particularly useful for distinguishing direct repression from indirect effects when combined with RNA-seq and binding assays. For repressors such as HIC1, knockout can reveal downstream pathways and phenotypes relevant to disease. Careful validation of editing and off-target analysis is essential for rigorous conclusions.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in the DNA-binding domain of a repressor to test how sequence variants affect GO:0001227 activity. This approach is valuable for modeling disease-associated SNPs identified through computational analysis, such as those in HIC1. Point-mutation models allow separation of DNA-binding defects from protein stability or interaction defects. Functional readouts include transcriptional reporters and target gene expression.
Knock-in
CRISPR knock-in can insert tags, reporters, or disease-relevant alleles at the endogenous locus of a repressor gene. Tagged knock-in enables occupancy profiling and interaction studies under native regulatory control. Knock-in of variant alleles supports functional dissection of SNPs predicted to affect repressor activity. These models are complementary to overexpression systems and reduce artifacts from non-physiological expression levels.
Overexpression
CRISPR overexpression can test whether increased levels of a repressor are sufficient to decrease transcription of target genes. This is useful for establishing sufficiency of GO:0001227 activity in a given cell context. Overexpression models can also be used to study dominant-negative or gain-of-function variants. Combining overexpression with knockout of candidate cofactors can reveal dependencies in the repression mechanism.
How EDITGENE Supports DNA-binding transcription repressor activity, RNA polymerase II-specific Research
Researchers studying DNA-binding transcription repressor activity, RNA polymerase II-specific-related genes often need to determine whether a candidate gene is causally involved in repressing target gene expression, and whether specific variants alter that function. EDITGENE provides CRISPR-based cell model services that enable knockout, point mutation, knock-in, overexpression, and library screening to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for DNA-binding transcription repressor activity, RNA polymerase II-specific research.
Frequently Asked Questions About DNA-binding transcription repressor activity, RNA polymerase II-specific
What is GO:0001227?
GO:0001227 is the Gene Ontology molecular function term for DNA-binding transcription repressor activity, RNA polymerase II-specific, which describes a transcription factor activity that represses or decreases transcription of specific gene sets transcribed by RNA polymerase II.
What does DNA-binding transcription repressor activity, RNA polymerase II-specific mean in simple terms?
It means a protein binds to specific DNA sequences and acts as a brake on transcription by RNA polymerase II, reducing the production of RNA from target genes.
What genes are involved in DNA-binding transcription repressor activity, RNA polymerase II-specific?
Genes encoding sequence-specific repressors such as HIC1, as well as cofactors and general transcription factors like PC4/Sub1, TFIIA, and TFIIAtau, are relevant to this activity and its regulatory context.
Where does this repressor activity occur in the genome?
It can occur at core promoter proximal regions and at distal enhancers, as reflected in the official synonyms of GO:0001227.
Is GO:0001227 a biological process or a molecular function?
GO:0001227 is a molecular function; it describes what the protein does at the molecular level rather than a larger biological process.
How is DNA-binding transcription repressor activity regulated?
It can be regulated at the level of DNA binding, cofactor recruitment, and post-translational modification, and some synonyms indicate metal ion-regulated DNA binding.
What diseases are associated with defects in RNA polymerase II-specific repressors?
Dysregulation of repressors such as HIC1 has been linked to cancer and developmental disorders, and broader transcriptional dysregulation is relevant to many diseases.
How can CRISPR be used to study GO:0001227?
CRISPR knockout, point mutation, knock-in, and overexpression models can test necessity and sufficiency of a candidate repressor and the impact of specific variants on transcription.
What methods measure DNA-binding transcription repressor activity?
RNA-seq, qRT-PCR, ChIP-seq, CUT&RUN, reporter assays, and computational SNP analysis are commonly used to measure repression and DNA binding.
Why is PC4/Sub1 relevant to RNA polymerase II repression?
PC4/Sub1 is a transcriptional coactivator with multiple functions in RNA polymerase II transcription, and its roles illustrate the balance between activation and repression.
Conclusion
GO:0001227, DNA-binding transcription repressor activity, RNA polymerase II-specific, defines a fundamental molecular function in which sequence-specific DNA-binding proteins repress transcription of target gene sets. Its importance spans development, cancer, and other diseases, and its study requires integrated computational and experimental approaches. The regulatory context includes coactivators such as PC4/Sub1 and general transcription factors like TFIIA and TFIIAtau, which together shape the balance of RNA polymerase II output. CRISPR-based cell models provide a rigorous path to test causality and variant effects for genes annotated with this activity.
References
- 1. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
- 2. Calvo O et al.. 2005. The transcriptional coactivator PC4/Sub1 has multiple functions in RNA polymerase II transcription.. EMBO J 24(5):1009-20 PMID: 15692559
- 3. Ozer J et al.. 2000. A testis-specific transcription factor IIA (TFIIAtau) stimulates TATA-binding protein-DNA binding and transcription activation.. J Biol Chem 275(1):122-8 PMID: 10617594
